Category: Diabetes

Insulin Biosimilars- A New Player in the Future of Diabetes Management

Partner Blog Series: American Society of Endocrine Physician Assistants (ASEPA)

In working to further our mission to help clinicians stay up-to-date on the latest education within cardiometabolic health, we have partnered with ASEPA to present the following blog to highlight a new and valuable clinical option in the practice of diabetes management.

Diabetes is a chronic illness that affects approximately 30.3 million people or 9.4% of the US population, and is associated with increased morbidity, mortality, and healthcare costs. Read more